ab61213 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab61213 は 27 報の論文で使用されています。

  • Grover P  et al. SMAD4-independent activation of TGF-ß signaling by MUC1 in a human pancreatic cancer cell line. Oncotarget 9:6897-6910 (2018). PubMed: 29467938
  • Li J  et al. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway. Cell Death Dis 8:e2965 (2017). PubMed: 28771231
  • Li X  et al. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Oncogene 36:5432-5438 (2017). WB . PubMed: 28534517
  • Chen YL  et al. MicroRNA-302d downregulates TGFBR2 expression and promotes hepatocellular carcinoma growth and invasion. Exp Ther Med 13:681-687 (2017). PubMed: 28352351
  • Yang H  et al. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep 7:41670 (2017). WB, IHC-P ; Human . PubMed: 28195144
  • Bianchi E  et al. Ghrelin Inhibits Post-Operative Adhesions via Blockage of the TGF-ß Signaling Pathway. PLoS One 11:e0153968 (2016). WB . PubMed: 27082244
  • Wang P  et al. Decorin reduces hypertrophic scarring through inhibition of the TGF-ß1/Smad signaling pathway in a rat osteomyelitis model. Exp Ther Med 12:2102-2108 (2016). WB ; Rat . PubMed: 27698699
  • Correia AC  et al. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-ß signaling. J Cell Sci 129:569-79 (2016). WB . PubMed: 26729221
  • Yumoto K  et al. Axl is required for TGF-ß2-induced dormancy of prostate cancer cells in the bone marrow. Sci Rep 6:36520 (2016). Human . PubMed: 27819283
  • Liu Y  et al. Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-ß receptor II. Exp Ther Med 12:2191-2195 (2016). WB ; Human . PubMed: 27698710
  • Luo SX  et al. TGF-ß Signaling in Dopaminergic Neurons Regulates Dendritic Growth, Excitatory-Inhibitory Synaptic Balance, and Reversal Learning. Cell Rep 17:3233-3245 (2016). IHC-Fr ; Mouse . PubMed: 28009292
  • Su CT  et al. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability. Hum Mol Genet 24:4024-36 (2015). PubMed: 25882708
  • Priyadarsini S  et al. Keratoconus in vitro and the key players of the TGF-ß pathway. Mol Vis 21:577-88 (2015). WB . PubMed: 26015770
  • Nurnberg ST  et al. Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap. PLoS Genet 11:e1005155 (2015). Mouse . PubMed: 26020946
  • Dinish US  et al. Actively targeted in vivo multiplex detection of intrinsic cancer biomarkers using biocompatible SERS nanotags. Sci Rep 4:4075 (2014). WB . PubMed: 24518045
  • Gray AL  et al. The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-ß-induced myofibroblast phenotypes through RhoA and ERK inhibition. PLoS One 9:e109208 (2014). WB ; Human . PubMed: 25272043
  • Serrano MJ  et al. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer. Oncotarget 5:7486-97 (2014). WB ; Human . PubMed: 25277187
  • Berndt S  et al. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-ß receptor activation. FASEB J 27:1309-21 (2013). PubMed: 23233533
  • Zong J  et al. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Lab Invest 93:1128-36 (2013). PubMed: 23958879
  • Jung CJ  et al. Human ESC Self-renewal Promoting microRNAs Induce Epithelial-Mesenchymal Transition in Hepatocytes by Controlling the PTEN and TGFß Tumor Suppressor Signaling Pathways. Mol Cancer Res 10:979-91 (2012). WB ; Human . PubMed: 22622027
  • Li WB  et al. Development of retinal pigment epithelium from human parthenogenetic embryonic stem cells and microRNA signature. Invest Ophthalmol Vis Sci 53:5334-43 (2012). PubMed: 22736612
  • Watanabe S  et al. A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells. Glycobiology 21:482-92 (2011). Mouse . PubMed: 21062784
  • Ahn JY  et al. The inhibitory effect of ginsan on TGF-ß mediated fibrotic process. J Cell Physiol 226:1241-7 (2011). Mouse . PubMed: 20945375
  • Mayoral R  et al. Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration. J Biol Chem 285:3633-42 (2010). PubMed: 19966340
  • Rajasekaran SA  et al. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther 9:1515-24 (2010). WB ; Pig . PubMed: 20501797
  • Wang H  et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-ß type II receptor. Brain Res 1357:166-74 (2010). PubMed: 20709030
  • Portela RF  et al. Pro-tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma. J Vet Intern Med 28:894-904 (0). PubMed: 24684686